NCT00630630View on ClinicalTrials.gov

Study on Safety and Efficacy of Levetiracetam in the Adjunctive Treatment of Female Subjects With C1 Catamenial Epilepsy

PHASE4CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

November 30, 2002

Primary Completion Date

November 30, 2003

Study Completion Date

November 30, 2003

Conditions
Epilepsy
Interventions
DRUG

Levetiracetam

OTHER

Placebo

Sponsors

Lead Sponsor

UCB Pharma
All Listed Sponsors
lead

UCB Pharma

INDUSTRY